Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Patient with a grade 4, IDH-mutant, MGMT-methylated glioma remains alive and progression-free for four years after receiving ...

New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...

New AI-driven applications launch seemingly every day, offering endless possibilities. AI can transform our immense body of ...

A recent study reveals rising early-onset colorectal cancer rates, highlighting disparities and the need for improved ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Patients who have completed colon cancer treatment could cut their risk of cancer-related death by 37% if they stick to a ...